Sage Journals: Discover world-class research

Retricted access

Research article

First published 1994-12

Cep Regimen (Ccnu,Etoposide,Prednimustine) for Relapsed/Refractory Hodgkin's Disease

Pier Luigi Zinzani, Enza Barbieri, Maurizio Bendandi [...]

Tumori Journal

Retricted access

Review article

First published 2016-4

Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease

Emily Ashjian, Kimberly Redic

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2022

Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation

Desiree Kunadt, Sylvia Herold, David Poitz [...]

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2021-9

Rituximab for treatment of refractory multiple sclerosis relapses during pregnancy

Chris Hollen, Jessica Rice, Michelle Park [...]

Multiple Sclerosis Journal

Free access

Review article

First published 2013-12

From clinical trials to clinical practice: single-agent carfilzomib adverse events and their management in patients with relapsed and/or refractory multiple myeloma

David S. Siegel

Therapeutic Advances in Hematology

Free access

Review article

First published 2012-12

Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use

Jeremy L. Warner, Jon E. Arnason

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2019-9

Vincristine,irinotecan,and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience

Sema Büyükkapu Bay, Rejin Kebudi, Omer Görgün [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023-1

Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis

Donald C Moore, Keren A Eagers, Amanda Janes [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2022-12

New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma

Donald C. Moore, Matthew R. Peery, Katherine A. Tobon [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 1999-7

Fludarabine Phosphate as an Active and Well Tolerated Salvage Therapy in an Elderly Heavily Pretreated Hodgkin's Disease Patient: A Case Report

Roberto Bordonaro, Francesco Ferraù, Dario Giuffrida [...]

Tumori Journal

Search results